E. Ohman J:Or Asset Management Ab Abbott Laboratories Transaction History

E. Ohman J:Or Asset Management Ab

$4.04 Trillion
Q3 2024

54 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 05, 2024	BUY	$100.78 - $112.29 $171,326 - $190,893	1,700 Added 2.2%	78,800 $8.59 Billion
Q1 2023 Apr 05, 2024	BUY	$96.86 - $114.01 $203,406 - $239,421	2,100 Added 2.8%	77,100 $7.81 Billion
Q4 2022 Apr 05, 2024	SELL	$95.06 - $111.52 $66,542 - $78,064	-700 Reduced 0.92%	75,000 $8.23 Billion
Q3 2022 Apr 05, 2024	SELL	$96.76 - $112.03 $251,576 - $291,278	-2,600 Reduced 3.32%	75,700 $7.32 Billion
Q2 2022 Apr 05, 2024	SELL	$102.07 - $123.37 $398,073 - $481,143	-3,900 Reduced 4.74%	78,300 $8.51 Billion
Q1 2022 Apr 05, 2024	BUY	$114.02 - $139.04 $9.37 Million - $11.4 Million	82,200 New	82,200 $9.73 Billion
Q4 2021 Apr 05, 2024	SELL	$115.53 - $141.46 $9.23 Million - $11.3 Million	-79,900 Closed	0 $0
Q3 2021 Apr 05, 2024	BUY	$116.66 - $129.06 $361,646 - $400,086	3,100 Added 4.04%	79,900 $9.44 Billion
Q2 2021 Apr 05, 2024	BUY	$105.79 - $124.53 $4.22 Million - $4.97 Million	39,900 Added 108.13%	76,800 $8.9 Billion
Q1 2021 Apr 05, 2024	BUY	$108.84 - $128.23 $90,772 - $106,943	834 Added 2.31%	36,900 $4.42 Billion
Q4 2020 Apr 05, 2024	SELL	$105.0 - $114.42 $283,500 - $308,934	-2,700 Reduced 6.96%	36,066 $3.95 Billion
Q3 2020 Apr 05, 2024	SELL	$91.64 - $111.29 $210,772 - $255,967	-2,300 Reduced 5.6%	38,766 $4.22 Billion
Q2 2020 Apr 05, 2024	BUY	$76.57 - $98.0 $84,226 - $107,800	1,100 Added 2.75%	41,066 $3.75 Billion
Q1 2020 Apr 05, 2024	SELL	$62.82 - $91.86 $288,972 - $422,556	-4,600 Reduced 10.32%	39,966 $3.15 Billion
Q4 2019 Apr 05, 2024	SELL	$78.51 - $87.4 $2.77 Million - $3.09 Million	-35,300 Reduced 44.2%	44,566 $3.87 Billion
Q3 2019 Apr 05, 2024	BUY	$81.84 - $88.74 $433,752 - $470,322	5,300 Added 7.11%	79,866 $6.68 Billion
Q2 2019 Apr 05, 2024	BUY	$72.88 - $85.0 $131,184 - $153,000	1,800 Added 2.47%	74,566 $6.27 Billion
Q1 2019 Apr 05, 2024	SELL	$66.22 - $80.06 $105,952 - $128,096	-1,600 Reduced 2.15%	72,766 $5.82 Billion
Q4 2018 Apr 05, 2024	SELL	$65.56 - $74.27 $655,600 - $742,700	-10,000 Reduced 11.85%	74,366 $5.38 Billion
Q3 2018 Apr 05, 2024	BUY	$60.81 - $73.36 $522,966 - $630,896	8,600 Added 11.35%	84,366 $6.19 Billion
Q2 2018 Apr 05, 2024	BUY	$57.57 - $63.54 $1.45 Million - $1.6 Million	25,200 Added 49.84%	75,766 $4.62 Billion
Q1 2018 Apr 05, 2024	SELL	$56.27 - $63.62 $39,389 - $44,534	-700 Reduced 1.37%	50,566 $3.03 Billion
Q4 2017 Apr 05, 2024	BUY	$53.68 - $57.47 $316,712 - $339,073	5,900 Added 13.01%	51,266 $2.93 Billion
Q3 2017 Apr 05, 2024	BUY	$48.06 - $53.64 $38,111 - $42,536	793 Added 1.78%	45,366 $2.42 Billion
Q1 2017 Apr 05, 2024	BUY	N/A	11,173 Added 33.45%	44,573 $1.98 Billion
Q4 2016 Apr 05, 2024	BUY	N/A	2,000 Added 6.37%	33,400 $1.28 Billion
Q3 2016 Apr 05, 2024	BUY	N/A	2,600 Added 9.03%	31,400 $1.33 Billion
Q3 2015 Apr 05, 2024	SELL	N/A	-3,400 Reduced 10.56%	28,800 $1.16 Billion
Q4 2014 Apr 05, 2024	SELL	N/A	-3,600 Reduced 10.06%	32,200 $1.47 Billion
Q1 2014 Apr 05, 2024	SELL	N/A	-3,800 Reduced 9.6%	35,800 $1.38 Billion
Q4 2013 Apr 05, 2024	SELL	N/A	-800 Reduced 1.98%	39,600 $1.52 Billion
Q3 2013 Apr 05, 2024	BUY	N/A	3,400 Added 9.19%	40,400 $1.34 Billion
Q2 2013 Apr 05, 2024	SELL	N/A	-3,900 Reduced 9.54%	37,000 $1.29 Billion
Q4 2012 Apr 05, 2024	BUY	N/A	1,200 Added 3.02%	40,900 $2.68 Billion
Q3 2012 Apr 05, 2024	BUY	N/A	500 Added 1.28%	39,700 $2.72 Billion
Q2 2012 Apr 05, 2024	SELL	N/A	-4,100 Reduced 9.47%	39,200 $2.53 Billion
Q1 2012 Apr 05, 2024	BUY	N/A	12,800 Added 41.97%	43,300 $2.65 Billion
Q4 2011 Apr 05, 2024	BUY	N/A	800 Added 2.69%	30,500 $1.72 Billion
Q3 2011 Apr 05, 2024	SELL	N/A	-4,300 Reduced 12.65%	29,700 $1.52 Billion
Q2 2011 Apr 05, 2024	BUY	N/A	1,500 Added 4.62%	34,000 $1.79 Billion
Q1 2011 Apr 05, 2024	BUY	N/A	7,400 Added 29.48%	32,500 $1.6 Billion
Q4 2010 Apr 05, 2024	SELL	N/A	-1,500 Reduced 5.64%	25,100 $1.2 Billion
Q2 2010 Apr 05, 2024	BUY	N/A	3,100 Added 13.19%	26,600 $1.24 Billion
Q1 2010 Apr 05, 2024	BUY	N/A	1,600 Added 7.31%	23,500 $1.24 Billion
Q4 2009 Apr 05, 2024	SELL	N/A	-5,200 Reduced 19.19%	21,900 $1.18 Billion
Q3 2009 Apr 05, 2024	BUY	N/A	2,100 Added 8.4%	27,100 $1.34 Billion
Q2 2009 Apr 05, 2024	BUY	N/A	4,300 Added 20.77%	25,000 $1.18 Billion
Q4 2008 Apr 05, 2024	BUY	N/A	2,400 Added 13.11%	20,700 $1.1 Billion
Q3 2008 Apr 05, 2024	SELL	N/A	-3,300 Reduced 15.28%	18,300 $1.05 Billion
Q2 2008 Apr 05, 2024	BUY	N/A	5,900 Added 37.58%	21,600 $1.14 Billion
Q4 2007 Apr 05, 2024	BUY	N/A	2,300 Added 17.16%	15,700 $882 Million
Q3 2007 Apr 05, 2024	BUY	N/A	900 Added 7.2%	13,400 $718 Million
Q1 2007 Apr 05, 2024	SELL	N/A	-100 Reduced 0.79%	12,500 $698 Million
Q4 2006 Apr 05, 2024	BUY	N/A	12,600	12,600 $614 Million

Others Institutions Holding ABT

# of Institutions

3,196

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.1 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.9 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.71 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.46 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.05 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.

Account